Evidence map›Paper›PMID 23225639›Full record

ArticleJournal of biomedical materials research. Part A2013

Incorporation of fibronectin to enhance cytocompatibility in multilayer elastin-like protein scaffolds for tissue engineering.

Swathi Ravi, Jeffrey M Caves, Adam W Martinez, Carolyn A Haller, Elliot L Chaikof

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Fabricated Elastin.Advanced healthcare materials · 2015
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Swathi RaviDepartment of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, Georgia 30332, USA.
Jeffrey M Caves
Adam W Martinez
Carolyn A Haller
Elliot L Chaikof
Emory University · USBeth Israel Deaconess Medical Center · USGeorgia Institute of Technology · USHarvard University · US

Funding

A Bioinspired Small Diameter Vascular ConduitR01HL083867 · NHLBI · EMORY UNIVERSITY · PI CHAIKOF, ELLIOT · 2006 to 2010
$3.8M
NHLBI NIH HHS R01 HL083867
6 · The paper itself

Abstract

Recombinant, elastin-like protein (ELP) polymers are of significant interest for the engineering of compliant, resilient soft tissues due to a wide range of tunable mechanical properties, biostability, and biocompatibility. Here, we enhance endothelial cell (EC) and mesenchymal stem cell compatibility with ELP constructs by addition of fibronectin (Fn) to the surface or bulk of ELP hydrogels. We find that cell adhesion, proliferation, and migration can be modulated by Fn addition. Adsorption of Fn to the hydrogel surface is more efficient than bulk blending. Surface immobilization of Fn by genipin crosslinking leads to stability without loss of bioactivity. Gels of varying mechanical modulus do not alter cell adhesion, proliferation, and migration in the range we investigate. However, more compliant gels promote an EC morphology suggesting tubulogenesis or network formation, whereas stiffer gels promote cobblestone morphology. Multilayer structures consisting of thin ELP sheets reinforced with collagen microfiber are fabricated and laminated through the culture of MSCs at layer interfaces. High cell viability in the resulting three-dimensional constructs suggests the applicability of Fn to the design of strong, resilient artificial blood vessels and other soft tissue replacements.

Indexed as

AnimalsBiocompatible MaterialsBlood VesselsCell AdhesionCell MovementCell ProliferationCollagenElastinEndothelial CellsExtracellular MatrixFibronectinsFluorescent Antibody TechniqueHydrogelsMechanical PhenomenaMesenchymal Stem CellsSwineBiocompatible MaterialsCollagenElastinFibronectinsHydrogels

Identifiers

PMID23225639
PMCPMC3880793
OpenAlexW1971827978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.